Tandem Diabetes Care, Inc. (TNDM): Price and Financial Metrics

Tandem Diabetes Care, Inc. (TNDM): $31.12

2.50 (+8.74%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

TNDM Price/Volume Stats

Current price $31.12 52-week high $44.05
Prev. close $28.62 52-week low $13.82
Day low $28.64 Volume 1,823,100
Day high $31.18 Avg. volume 1,885,964
50-day MA $25.83 Dividend yield N/A
200-day MA $24.75 Market Cap 2.04B

TNDM Stock Price Chart Interactive Chart >

TNDM POWR Grades

  • TNDM scores best on the Value dimension, with a Value rank ahead of 74.79% of US stocks.
  • The strongest trend for TNDM is in Stability, which has been heading down over the past 26 weeks.
  • TNDM ranks lowest in Sentiment; there it ranks in the 6th percentile.

TNDM Stock Summary

  • TANDEM DIABETES CARE INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 77.43% of US listed stocks.
  • In terms of twelve month growth in earnings before interest and taxes, TANDEM DIABETES CARE INC is reporting a growth rate of 228.68%; that's higher than 94.84% of US stocks.
  • In terms of volatility of its share price, TNDM is more volatile than 81.9% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to TANDEM DIABETES CARE INC are PHR, MXCT, HCAT, NTCT, and DDD.
  • TNDM's SEC filings can be seen here. And to visit TANDEM DIABETES CARE INC's official web site, go to www.tandemdiabetes.com.

TNDM Valuation Summary

  • In comparison to the median Healthcare stock, TNDM's price/sales ratio is 13.64% higher, now standing at 2.5.
  • Over the past 122 months, TNDM's price/sales ratio has gone down 17.9.

Below are key valuation metrics over time for TNDM.

Stock Date P/S P/B P/E EV/EBIT
TNDM 2023-12-29 2.5 6.1 -9.3 -11.6
TNDM 2023-12-28 2.6 6.4 -9.6 -12.0
TNDM 2023-12-27 2.6 6.4 -9.7 -12.1
TNDM 2023-12-26 2.6 6.4 -9.7 -12.1
TNDM 2023-12-22 2.5 6.1 -9.2 -11.6
TNDM 2023-12-21 2.5 6.1 -9.2 -11.5

TNDM Growth Metrics

    The 4 year revenue growth rate now stands at 374.03%.
  • The 2 year price growth rate now stands at 18.36%.
  • Its 2 year net income to common stockholders growth rate is now at 135.45%.
Over the past 52 months, TNDM's revenue has gone up $653,255,000.

The table below shows TNDM's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 801.217 50.464 -94.594
2022-09-30 790.712 64.279 -67.933
2022-06-30 765.792 74.48 -13.169
2022-03-31 737.669 96.474 5.895
2021-12-31 702.799 111.359 15.566
2021-09-30 660.868 106.961 21.758

TNDM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • TNDM has a Quality Grade of C, ranking ahead of 66.11% of graded US stocks.
  • TNDM's asset turnover comes in at 0.848 -- ranking 30th of 186 Medical Equipment stocks.
  • IVC, TCMD, and PSTV are the stocks whose asset turnover ratios are most correlated with TNDM.

The table below shows TNDM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.848 0.534 0.036
2021-06-30 0.823 0.532 0.024
2021-03-31 0.785 0.523 -0.018
2020-12-31 0.849 0.522 -0.045
2020-09-30 0.897 0.524 -0.109
2020-06-30 1.040 0.526 -0.154

TNDM Price Target

For more insight on analysts targets of TNDM, see our TNDM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $132.75 Average Broker Recommendation 1.62 (Moderate Buy)

Tandem Diabetes Care, Inc. (TNDM) Company Bio


Tandem Diabetes Care, Inc. focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes in the United States. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. The company was founded in 2006 and is based in San Diego, California.


TNDM Latest News Stream


Event/Time News Detail
Loading, please wait...

TNDM Latest Social Stream


Loading social stream, please wait...

View Full TNDM Social Stream

Latest TNDM News From Around the Web

Below are the latest news stories about TANDEM DIABETES CARE INC that investors may wish to consider to help them evaluate TNDM as an investment opportunity.

DexCom's (DXCM) G7 CGM Connects With Tandem's Insulin Pump

Dexcom's (DXCM) G7 integrates with Tandem's t:slim X2, revolutionizing diabetes care. A perfect combination of accuracy and innovation, this synergy sets a new standard in continuous glucose monitoring.

Yahoo | December 19, 2023

Here's Why You Should Retain Tandem Diabetes (TNDM) Now

Investors remain optimistic about Tandem Diabetes (TNDM), backed by the impressive spree of product introductions.

Yahoo | December 19, 2023

Tandem Diabetes (TNDM) Avails Tandem Source in the United States

Tandem Diabetes (TNDM) announces the full U.S. launch of Tandem Source, a new diabetes management platform for customers and healthcare providers.

Yahoo | December 14, 2023

Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers

SAN DIEGO, December 12, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the launch of Tandem Source, a diabetes management platform for insulin pump users and healthcare providers (HCPs). Tandem Source is designed to bring together the features of Tandem’s legacy t:connect, t:connect HCP, and t:connect Portal offerings with new comprehensive data reporting in one central, scalable platform. Tandem Source is now availabl

Yahoo | December 12, 2023

Tandem Diabetes (TNDM) Launches Dexcom G7 Integrated t:slim X2

Tandem Diabetes' (TNDM) t:slim X2 is the first AID system in the world to feature Dexcom's most advanced CGM technology.

Yahoo | December 7, 2023

Read More 'TNDM' Stories Here

TNDM Price Returns

1-mo 27.44%
3-mo 12.96%
6-mo 46.52%
1-year -25.21%
3-year -65.31%
5-year -57.69%
YTD 5.21%
2023 -34.19%
2022 -70.14%
2021 57.32%
2020 60.51%
2019 56.99%

Continue Researching TNDM

Here are a few links from around the web to help you further your research on Tandem Diabetes Care Inc's stock as an investment opportunity:

Tandem Diabetes Care Inc (TNDM) Stock Price | Nasdaq
Tandem Diabetes Care Inc (TNDM) Stock Quote, History and News - Yahoo Finance
Tandem Diabetes Care Inc (TNDM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!